[89Zr]-DFO-DLL3-scFv

N/A

Report date: 2025/11/04 16:07:44

NME

Base Information

Drug Name[89Zr]-DFO-DLL3-scFv

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionDelta-like protein 3 binders

TargetsDelta-like protein 3

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUc San Francisco

China Registration ClassN/A

Develop Information

Active CompaniesUc San Francisco

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A